paper describes how PET could predict PFS of patients affected by follicular lymphoma and how MRD molecularly detected would be a further stratification markers in PET-negative cases.
No takes yet. Share an insight, caveat, or question.
Luminari et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: